奥泰生物
(688606)
| 流通市值：53.88亿 | | | 总市值：53.88亿 |
| 流通股本：7928.09万 | | | 总股本：7928.09万 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 984,395,729.24 | 1,109,040,433.87 | 896,273,258.64 | 920,378,161.07 |
| 交易性金融资产 | 1,474,239,693.39 | 1,352,203,196.7 | 1,651,558,745.59 | 1,657,359,980.9 |
| 应收票据及应收账款 | 166,099,916.85 | 152,431,929.22 | 142,515,224.93 | 125,118,782.69 |
| 其中：应收票据 | - | - | - | 792,000 |
| 应收账款 | 166,099,916.85 | 152,431,929.22 | 142,515,224.93 | 124,326,782.69 |
| 预付款项 | 23,463,824.07 | 13,422,531.98 | 24,929,429.54 | 13,680,304.17 |
| 其他应收款合计 | 5,985,528.48 | 6,322,243.09 | 9,013,691.35 | 6,667,192.9 |
| 存货 | 180,710,380.01 | 167,094,257.71 | 162,001,788.31 | 160,321,121.43 |
| 其他流动资产 | 92,750,282.42 | 90,456,616.33 | 89,260,600.52 | 81,773,781.61 |
| 流动资产合计 | 2,927,645,354.46 | 2,890,971,208.9 | 2,975,552,738.88 | 2,965,299,324.77 |
| 非流动资产: | | | | |
| 长期股权投资 | 81,367,856.18 | 61,306,928.21 | 61,500,631.65 | 41,583,105.01 |
| 其他权益工具投资 | 17,847,856.6 | 17,847,856.6 | 17,847,856.6 | 17,847,856.6 |
| 其他非流动金融资产 | 18,000,000 | 9,000,000 | 9,000,000 | 59,000,000 |
| 投资性房地产 | 54,351,788.94 | 54,693,228.18 | 55,034,667.42 | 48,659,082.58 |
| 固定资产 | 421,703,815.01 | 423,460,261.87 | 427,649,913.07 | 439,245,873.7 |
| 在建工程 | 520,475,291.52 | 508,251,133.47 | 507,356,411.4 | 459,922,387.7 |
| 使用权资产 | 8,338,746.28 | 2,934,559.59 | 3,545,226.61 | 4,267,070.79 |
| 无形资产 | 138,271,522.31 | 122,306,513.3 | 103,782,166.12 | 104,973,855.84 |
| 长期待摊费用 | 9,652,538.55 | 8,081,015.4 | 9,092,681.41 | 10,345,629.43 |
| 递延所得税资产 | 22,987,203.13 | 25,277,388.51 | 23,119,796.07 | 22,204,671.83 |
| 其他非流动资产 | 21,384,365.44 | 29,882,255.14 | 11,388,337 | 12,671,300 |
| 非流动资产合计 | 1,314,380,983.96 | 1,263,041,140.27 | 1,229,317,687.35 | 1,220,720,833.48 |
| 资产总计 | 4,242,026,338.42 | 4,154,012,349.17 | 4,204,870,426.23 | 4,186,020,158.25 |
| 流动负债: | | | | |
| 交易性金融负债 | 28,497,627 | 28,004,860 | 28,692,361 | 28,724,990 |
| 应付票据及应付账款 | 67,440,960.59 | 59,892,770.12 | 68,181,755.02 | 104,799,237.87 |
| 应付账款 | 67,440,960.59 | 59,892,770.12 | 68,181,755.02 | 104,799,237.87 |
| 预收款项 | 448,272.8 | 805,616 | 1,314,605.23 | 515,312.09 |
| 合同负债 | 41,142,999.8 | 35,034,731.95 | 48,778,507.15 | 40,840,391.22 |
| 应付职工薪酬 | 19,188,365.95 | 17,106,761.11 | 10,589,387.91 | 27,616,044.79 |
| 应交税费 | 92,167,955.54 | 98,591,401.65 | 90,408,287.24 | 92,943,744.63 |
| 其他应付款合计 | 79,877,670.2 | 834,565.33 | 3,294,036.27 | 950,048.52 |
| 应付股利 | 78,307,224 | - | - | - |
| 一年内到期的非流动负债 | 289,510.54 | 2,671,295.7 | 2,676,951.62 | 2,336,630.68 |
| 其他流动负债 | 488,046.86 | 276,755.27 | 360,155.22 | 461,627.13 |
| 流动负债合计 | 329,541,409.28 | 243,218,757.13 | 254,296,046.66 | 299,188,026.93 |
| 非流动负债: | | | | |
| 租赁负债 | 7,959,784.17 | 259,223.92 | 1,487,635.51 | 1,760,289.21 |
| 递延收益 | 3,166,384.75 | 2,777,637.53 | 1,390,200.58 | 1,640,265.11 |
| 递延所得税负债 | 11,274.11 | - | 11,274.11 | 11,274.11 |
| 非流动负债合计 | 11,137,443.03 | 3,036,861.45 | 2,889,110.2 | 3,411,828.43 |
| 负债合计 | 340,678,852.31 | 246,255,618.58 | 257,185,156.86 | 302,599,855.36 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 79,280,855 | 79,280,855 | 79,280,855 | 79,280,855 |
| 资本公积 | 1,696,590,330.09 | 1,717,340,097.72 | 1,711,025,473.26 | 1,707,661,785.48 |
| 减:库存股 | 77,897,481.18 | 113,011,953.53 | 113,011,953.53 | 113,011,953.53 |
| 其他综合收益 | 31,889,034.24 | 31,854,520.62 | 32,225,196.33 | 32,499,360.87 |
| 盈余公积 | 266,191,150.02 | 266,191,150.02 | 266,191,150.02 | 266,191,150.02 |
| 未分配利润 | 1,905,719,944.46 | 1,926,230,159.26 | 1,972,236,254.59 | 1,911,019,965.65 |
| 归属于母公司股东权益合计 | 3,901,773,832.63 | 3,907,884,829.09 | 3,947,946,975.67 | 3,883,641,163.49 |
| 少数股东权益 | -426,346.52 | -128,098.5 | -261,706.3 | -220,860.6 |
| 股东权益合计 | 3,901,347,486.11 | 3,907,756,730.59 | 3,947,685,269.37 | 3,883,420,302.89 |
| 负债和股东权益合计 | 4,242,026,338.42 | 4,154,012,349.17 | 4,204,870,426.23 | 4,186,020,158.25 |
| 公告日期 | 2025-10-31 | 2025-08-30 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |